Mouse Cardiomyocytes

Cat.No.: CSC-C5355S

Species: Mouse

Source: Heart

Cell Type: Cardiomyocyte

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C5355S
Description
Cardiomyocytes are the cells responsible for generating contractile force in the intact heart. Specialized cardiomyocytes form the cardiac conduction system, responsible for control of rhythmic beating of the heart.
Mouse cardiomyocytes from Creative Bioarray are isolated from mouse heart tissue. The method we use to isolate mouse cardiomyocytes was developed based on a combination of established and our proprietary methods. The mouse cardiomyocytes from Creative Bioarray are characterized by immunofluorescence with antibodies specific to myosin heavy chain. Each vial contains 0.5x10^6 cells per ml and is delivered frozen.
Species
Mouse
Source
Heart
Recommended Medium
SuperCult® Mouse Cardiomyocyte Cell Medium
Cell Type
Cardiomyocyte
Disease
Normal
Quality Control
Mouse Cardiomyocytes are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Never can cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Mouse cardiomyocytes are cells that make up cardiac muscle tissue. Cardiomyocytes are of particular interest for cardiovascular study as they provide an in vivo look into cardiac contraction, electrophysiology, and disease progression. Mouse cardiomyocytes are often isolated from neonatal or adult mouse heart tissue and can be distinguished by the organized nature of their sarcomeres and dense mitochondrial populations responsible for their rhythmic and involuntary contractions. Neonatal cardiomyocytes are typically preferred for study in the field due to their ability to be more easily cultured and their reduced proliferative ability; however, adult cardiomyocytes are sometimes used as their shape and maturation state more closely represent an in vivo heart. Mouse cardiomyocytes, both neonatal and adult, are used to study calcium handling and signaling, ion channel kinetics, and cardiotoxicity of developing drugs.

Inhibition of Glycolysis Pathway Activity by 2DG Attenuates SARS-Cov-2 Nsp6-Induced Functional Defect in Mouse Cardiomyocytes

Infection with SARS-CoV-2 leads to COVID-19, a disease characterized by severe respiratory illness and cardiovascular complications. Zhu's team explored the direct impact of SARS-CoV-2 proteins on heart function in Drosophila and mouse models, focusing on a viral protein, Nsp6, that interacts with the host protein MGA/MAX and dysregulates cardiac metabolism.

Nsp6 was found to directly interact with MGA/MAX, which activates glycolysis and disrupts mitochondria, leading to increased ROS. To test whether their observations in flies also hold true in mammals, they isolated heart cells from mouse embryos and added the SARS-CoV-2 Nsp6 gene. They assessed markers of heart cell enlargement (hypertrophy) because dysfunction in cardiac sugar metabolism is known to cause hypertrophy. The Nsp6 gene triggered a rise in ANP and BNP production which indicates cardiac hypertrophy, and they also upregulated genes involved in glycolysis (sugar breakdown). 2DG (a glycolysis inhibitor) treatment rescued all of these changes. Heart cells expressing Nsp6 had prolonged calcium uptake duration, which is important for heart muscle contraction and relaxation. 2DG treatment rescued the calcium uptake duration back to normal levels. Thus, the SARS-CoV-2 protein Nsp6 impairs mouse heart function by altering sugar metabolism and blocking this pathway with 2DG can rescue the heart cell dysfunction.

Inhibiting glycolysis activity by 2DG attenuates SARS-CoV-2 Nsp6-induced heart hypertrophy and functional defects in mouse primary cardiomyocytes.

Fig. 1. Inhibiting glycolysis activity by 2DG attenuates SARS-CoV-2 Nsp6-induced heart hypertrophy and functional defects in mouse primary cardiomyocytes (Zhu J Y, Wang G L, et al., 2022).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products